Xlife Sciences AG
SIX:XLS
Xlife Sciences AG
SIX:XLS
Price:
21.5
CHF
-1.38%
Market Closed
Market Cap:
CHf124.1m
Xlife Sciences AG
Inventory
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Xlife Sciences AG
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Xlife Sciences AG
SIX:XLS
|
Inventory
CHf45.4k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bachem Holding AG
SIX:BANB
|
Inventory
CHf482.9m
|
CAGR 3-Years
16%
|
CAGR 5-Years
15%
|
CAGR 10-Years
13%
|
|
|
Siegfried Holding AG
SIX:SFZN
|
Inventory
CHf471.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Lonza Group AG
SIX:LONN
|
Inventory
CHf1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
|
Tecan Group AG
SIX:TECN
|
Inventory
CHf215.4m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
SKAN Group AG
SIX:SKAN
|
Inventory
CHf113.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Xlife Sciences AG
Glance View
Xlife Sciences AG focuses on the value development of performance promising technologies in life sciences. The company is headquartered in Zurich, Zuerich and currently employs 19 full-time employees. The company went IPO on 2019-09-30. The firm focuses on investing in technologies in the life science industry. The company supports researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. The firm offers its investors direct access to the further development of technologies at a very early stage. The firm cooperates with industrial partners and universities.
XLS
Intrinsic Value
1.31
CHF
Overvaluation 94%
See Also
What is Xlife Sciences AG's Inventory?
Inventory
45.4k
CHF
45.4k
CHF
Based on the financial report for Dec 31, 2024, Xlife Sciences AG's Inventory amounts to 45.4k CHF.
